By physician referral or invitation only

The Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation

This study is comparing two ways of treating Atrial Fibrillation (AF). Patients will either take continuous anticoagulation medications, or they will wear AF-sensing smartwatches and take anticoagulation medications for 30 days after an AF event.

Age & Gender

22 years ~ 85 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Anil Gehi
Medicine - Cardiology

Study Type

Clinical or Medical
Interventional

Study Topics

Heart and Circulation

IRB Number

23-1411

ClinicalTrials.gov

NCT05836987

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.